+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Treatment of Epstein Barr infection

Treatment of Epstein Barr infection

Official Gazette of the United States Patent & Trademark Office Patents 1237(4), Aug 22

A method of treating Epstein Barr virus infection in humans by administering a pharmaceutically effective amount of an antiviral agent selected from a group consisting of acyclovir, famciclovir, valacyclovir and a pharmaceutically acceptable salt thereof is provided.

(PDF emailed within 1 workday: $29.90)

Accession: 035980398

Download citation: RISBibTeXText

Related references

Establishment of epstein barr virus nuclear antigen expressing cell lines by infection of epstein barr virus genome negative human lymphoma cells with different epstein barr virus strains. International Journal Of Cancer: 161-166, 1976

Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin. Cancer Letters 376(2): 240-248, 2017

Relationship between the amounts of epstein barr virus dna and epstein barr virus nuclear antigen per cell clonability and tumorigenicity in 2 epstein barr virus negative lymphoma lines and their epstein barr virus converted sublines. International Journal of Cancer 31(2): 163-170, 1983

Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis. Plos One 13(12): E0208957-E0208957, 2018

Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in a patient with chronic active Epstein-Barr infection. DMW Deutsche Medizinische Wochenschrift 128(11): 548-550, 14 Maerz, 2003

Pathogenesis of epstein barr virus infection the host range of epstein barr now includes epithelial cells. Rapp, F (Ed ) Ucla (University Of California Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 21 Herpesvirus; Meeting, Steamboat Springs, Colo , Usa, Apr 8-13, 1984 Xxiv+715p Alan R Liss, Inc : New York, N Y , Usa Illus 239-252, 1984, 1985

Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection. Deutsche Medizinische Wochenschrift 128(11): 548-550, 2003

Successful treatment of immediate allogeneic myeloablative hematopoietic stem cell transplantation from a HLA-mismatched sibling donor for active systemic epstein-barr virus-positive T-cell lymphoproliferative disease of childhood following primary acute epstein-barr virus infection. Clinical Case Reports 3(4): 231-236, 2015

Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans. American Journal of Pathology 145(4): 969-978, 1994

Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. Journal of Pediatrics 120(2 Pt 1): 228-232, 1992

Polyclonal proliferation of lymphocytes containing the epstein-barr virus genome in a patient dying of myocarditis in chronic active Epstein-Barr virus infection. Journal of Pediatric Hematology/Oncology 25(1): 85-88, 2003

Sensitivity of epstein barr virus producer and nonproducer human lympho blastoid cell lines to super infection with epstein barr virus. International Journal Of Cancer: 44-57, 1972

Multiplicity dependent biological and biochemical properties of epstein barr virus rescued from nonproducer lines after super infection with p 3hr 1 epstein barr virus. International Journal of Cancer 26(3): 357-364, 1980

Prevention of epstein barr virus induced infection in cotton topped marmosets by human serum containing epstein barr virus neutralizing activity. De-The, G , M A Epstein And H Zur Hausen (Ed ) Iarc (International Agency For Research on Cancer) Scientific Publications, No 11 Oncogenesis And Herpesviruses Ii, Part 2 Epidemiology, Host Response And Control Proceedings Of A Symposium Nuremberg, West Germany, Oct 14-16, 1974 Xiii+403p Illus International Agency For Research on Cancer: Lyon, France (Dist By Who, Geneva, Switzerland) 153-159, 1975

Infiltrations of Epstein-Barr virus-carrying cells in granular lymphocyte-proliferative disorders corresponding to chronic active Epstein-Barr virus infection. Pediatric Hematology and Oncology 19(7): 459-465, 2002